177 related articles for article (PubMed ID: 38743428)
1. Targeting respiratory microbiomes in COPD and bronchiectasis.
Mac Aogáin M; Tiew PY; Jaggi TK; Narayana JK; Singh S; Hansbro PM; Segal LN; Chotirmall SH
Expert Rev Respir Med; 2024; 18(3-4):111-125. PubMed ID: 38743428
[TBL] [Abstract][Full Text] [Related]
2. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap.
Tiew PY; Jaggi TK; Chan LLY; Chotirmall SH
Clin Respir J; 2021 Feb; 15(2):123-133. PubMed ID: 33063421
[TBL] [Abstract][Full Text] [Related]
3. The contribution of respiratory microbiome analysis to a treatable traits model of care.
Taylor SL; O'Farrell HE; Simpson JL; Yang IA; Rogers GB
Respirology; 2019 Jan; 24(1):19-28. PubMed ID: 30282116
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
Ghosh A; Saha S
J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
[No Abstract] [Full Text] [Related]
5. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.
Mac Aogáin M; Lau KJX; Cai Z; Kumar Narayana J; Purbojati RW; Drautz-Moses DI; Gaultier NE; Jaggi TK; Tiew PY; Ong TH; Siyue Koh M; Lim Yick Hou A; Abisheganaden JA; Tsaneva-Atanasova K; Schuster SC; Chotirmall SH
Am J Respir Crit Care Med; 2020 Aug; 202(3):433-447. PubMed ID: 32320621
[No Abstract] [Full Text] [Related]
6. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.
Ni Y; Shi G; Yu Y; Hao J; Chen T; Song H
Int J Chron Obstruct Pulmon Dis; 2015; 10():1465-75. PubMed ID: 26251586
[TBL] [Abstract][Full Text] [Related]
7. Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.
Garth J; Barnes JW; Krick S
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380761
[TBL] [Abstract][Full Text] [Related]
8. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
9. Restoring the epigenetic landscape of lung microbiome: potential therapeutic approach for chronic respiratory diseases.
KavianFar A; Taherkhani H; Ahmadi A; Salimi M; Lanjanian H; Masoudi-Nejad A
BMC Pulm Med; 2024 Jan; 24(1):2. PubMed ID: 38166878
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
11. The lung microbiome and exacerbations of COPD.
Dy R; Sethi S
Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
[TBL] [Abstract][Full Text] [Related]
12. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
[TBL] [Abstract][Full Text] [Related]
13. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
Sethi S
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
[TBL] [Abstract][Full Text] [Related]
14. The lung microbiome in health and disease.
Moffatt MF; Cookson WO
Clin Med (Lond); 2017 Dec; 17(6):525-529. PubMed ID: 29196353
[TBL] [Abstract][Full Text] [Related]
15. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
[No Abstract] [Full Text] [Related]
16. Bacterial vaccines in chronic obstructive pulmonary disease: effects on clinical outcomes and cytokine levels.
Ruso S; Marco FM; Martínez-Carbonell JA; Carratalá JA
APMIS; 2015 Jul; 123(7):556-61. PubMed ID: 26010477
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease.
Di Pasquale M; Aliberti S; Mantero M; Gramegna A; Blasi F
Expert Opin Pharmacother; 2020 Nov; 21(16):1975-1990. PubMed ID: 32808825
[TBL] [Abstract][Full Text] [Related]
18. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
[TBL] [Abstract][Full Text] [Related]
19. Bacterial microbiome of lungs in COPD.
Sze MA; Hogg JC; Sin DD
Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
[TBL] [Abstract][Full Text] [Related]
20. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
